Prostatic artery embolisation (PAE)
Benign enlargement of the prostate (BPH) is the most common type of benign tumour in men and primarily occurs in later life. More than half of men over 60 have this type of organ enlargement, with the number increasing to 70% over 70. However only just under a third of them will develop symptoms that impact on their quality of life.
Symptomatic BPH is initially treated with medications, which allows mild symptoms to be controlled effectively. If this treatment is not sufficient, patients are generally advised to have part of their prostate surgically removed. PAE provides a new, minimally invasive alternative to surgery for such cases.